Clinicopathological, genetic, ultrastructural characterizations and prognostic factors of papillary renal cell carcinoma: New diagnostic and prognostic information

Acta Histochemica

Volumn 115, Issue 5, 2013, Pages 452-459

  Yu, Wenjuan ^a   Zhang, Wei ^b   Jiang, Yanxia ^a   Wang, Yuewei ^a   Li, Yujun ^a   Wang, Jigang ^a   Sun, Lingling ^a   Ran, Wenwen ^a   Li, Hong ^a  

^a QINGDAO UNIVERSITY   (China)

^b Troop 92001 of the People's Liberation Army   (China)

Author keywords

Genetics; Immunohistochemistry; Papillary renal cell carcinoma; Prognosis; Renal neoplasms; Ultrastructure

Indexed keywords

CARBONATE DEHYDRATASE IX; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; CYTOKERATIN 7; EPITHELIAL MEMBRANE ANTIGEN; GLYCOGEN; P504S PROTEIN; TRANSCRIPTION FACTOR PAX2; TRANSCRIPTION FACTOR PAX8; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CELL ULTRASTRUCTURE; CHROMOSOME 11; CHROMOSOME 17; CHROMOSOME 18; CHROMOSOME 7; CHROMOSOME ABERRATION; CHROMOSOME LOSS; DIFFERENTIAL DIAGNOSIS; ENZYME LOCALIZATION; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENETIC ANALYSIS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; LYSOSOME; MAJOR CLINICAL STUDY; MALE; MITOCHONDRION; PAPILLARY RENAL CELL CARCINOMA; PROTEIN EXPRESSION; SMOOTH ENDOPLASMIC RETICULUM; TRANSMISSION ELECTRON MICROSCOPY; Y CHROMOSOME;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, NEOPLASM; CARBONIC ANHYDRASES; CARCINOMA, RENAL CELL; CHROMOSOME ABERRATIONS; ENDOPLASMIC RETICULUM, SMOOTH; FEMALE; GLYCOGEN; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KAPLAN-MEIER ESTIMATE; KIDNEY NEOPLASMS; LYSOSOMES; MALE; MICROSCOPY, ELECTRON, TRANSMISSION; MIDDLE AGED; MITOCHONDRIA; PROGNOSIS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 84879843091     PISSN: 00651281     EISSN: 16180372     Source Type: Journal    
DOI: 10.1016/j.acthis.2012.10.009     Document Type: Article

References (24)

1. Abrahams N.A., MacLennan G.T., Khoury J.D., Ormsby A.H., Tamboli P., Doglioni C., et al. Chromophobe renal cell carcinoma: a comparative study of histological, immunohistochemical and ultrastructural features using high throughput tissue microarray. Histopathology 2004, 45:593-602.
2. Allory Y., Ouazana D., Boucher E., Thiounn N., Vieillefond A. Papillary renal cell carcinoma. Prognostic value of morphological subtypes in a clinicopathologic study of 43 cases. Virchows Arch 2003, 442:336-342.
3. Amin M.B., Amin M.B., Tamboli P., Javidan J., Stricker H., de-Peralta Venturina M., et al. Prognostic impact of histologic subtyping of adult renal epithelial neoplasms: an experience of 405 cases. Am J Surg Pathol 2002, 26:281-291.
4. Bui M.H., Visapaa H., Seligson D., Kim H., Han K.R., Huang Y., et al. Prognostic value of carbonic anhydrase IX and KI67 as predictors of survival for renal clear cell carcinoma. J Urol 2004, 171:2461-2466.
5. Coffin C.M., Swanson P.E., Wick M.R., Dehner L.P. An immunohistochemical comparison of chordoma with renal cell carcinoma, colorectal adenocarcinoma, and myxopapillary ependymoma: a potential diagnostic dilemma in the diminutive biopsy. Mod Pathol 1993, 6:531-538.
6. Delahunt B., Eble J.N. Papillary renal cell carcinoma: a clinicopathologic and immunohistochemical study of 105 tumors. Mod Pathol 1997, 10:537-544.
7. Delahunt B., Eble J.N., McCredie M.R., Bethwaite P.B., Stewart J.H., Bilous A.M. Morphologic typing of papillary renal cell carcinoma: comparison of growth kinetics and patient survival in 66 cases. Hum Pathol 2001, 32:590-595.
8. World health organization classification of tumours. Pathology and genetics of tumours of the urinary system and male genital organs 2004, IARC Press, Lyon. J.N. Eble, G. Sauter, J.I. Epstein, Sesterhenn IA (Eds.).
9. Fonsato V., Buttiglieri S., Deregibus M.C., Puntorieri V., Bussolati B., Camussi G. Expression of Pax2 in human renal tumor-derived endothelial cells sustains apoptosis resistance and angiogenesis. Am J Pathol 2006, 168:706-713.
10. Fromont G., Barcat L., Gaudin J., Irani J. Revisiting the immunophenotype of nephrogenic adenoma. Am J Surg Pathol 2009, 33:1654-1658.
11. Fuhrman S.A., Lasky L.C., Limas C. Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 1982, 6:655-663.
12. Gilmore L., Dewar R. Caution in metastatic renal cell carcinoma within lymph nodes: PAX-2 expression is also seen in nodal lymphocytes. Arch Pathol Lab Med 2011, 135:414.
13. Gudbjartsson T., Thoroddsen A., Petursdottir V., Hardarson S., Magnusson J., Einarsson G.V. Effect of incidental detection for survival of patients with renal cell carcinoma: results of population-based study of 701 patients. Urology 2005, 66:1186-1191.
14. Gunawan B., Huber W., Holtrup M., von Heydebreck A., Efferth T., Poustka A., et al. Prognostic impacts of cytogenetic findings in clear cell renal cell carcinoma: gain of 5q31-qter predicts a distinct clinical phenotype with favorable prognosis. Cancer Res 2001, 61:7731-7738.
15. Gunawan B., von Heydebreck A., Fritsch T., Huber W., Ringert R.H., Jakse G., et al. Cytogenetic and morphologic typing of 58 papillary renal cell carcinomas: evidence for a cytogenetic evolution of Type 2 from Type 1 tumors. Cancer Res 2003, 63:6200-6205.
16. Herts B.R., Coll D.M., Novick A.C., Obuchowski N., Linnell G., Wirth S.L., et al. Enhancement characteristics of papillary renal neoplasms revealed on triphasic helical CT of the kidneys. AJR Am J Roentgenol 2002, 178:367-372.
17. Kosaka T., Mikami S., Miyajima A., Kikuchi E., Nakagawa K., Ohigashi T., et al. Papillary renal cell carcinoma: clinicopathological characteristics in 40 patients. Clin Exp Nephrol 2008, 12:195-199.
18. Moch H., Gasser T., Amin M.B., Torhorst J., Sauter G., Mihatsch M.J. Prognostic utility of the recently recommended histologic classification and revised TNM staging system of renal cell carcinoma: a Swiss experience with 588 tumors. Cancer 2000, 89:604-614.
19. Ogawa O., Kakehi Y., Ogawa K., Koshiba M., Sugiyama T., Yoshida O., et al. Allelic loss at chromosome 3p characterizes clear cell phenotype of renal cell carcinoma. Cancer Res 1991, 51:949-953.
20. Pignot G., Elie C., Conquy S., Vieillefond A., Flam T., Zerbib M., et al. Survival analysis of 130 patients with papillary renal cell carcinoma: prognostic utility of type 1 and type 2 subclassification. Urology 2007, 69:230-235.
21. Renshaw A.A., Corless C.L. Papillary renal cell carcinoma. Histology and immunohistochemistry. Am J Surg Pathol 1995, 19:842-849.
22. Sanders M.E., Mick R., Tomaszewski J.E., Barr F.G. Unique patterns of allelic imbalance distinguish type 1 from type 2 sporadic papillary renal cell carcinoma. Am J Pathol 2002, 161:997-1005.
23. Shen S.S., Krishna B., Chirala R., Amato R.J., Truong L.D. Kidney-specific cadherin, a specific marker for the distal portion of the nephron and related renal neoplasms. Mod Pathol 2005, 18:933-940.
24. Tretiakova M.S., Sahoo S., Takahashi M., Turkyilmaz M., Vogelzang N.J., Lin F., et al. Expression of alpha-methylacyl-CoA racemase in papillary renal cell carcinoma. Am J Surg Pathol 2004, 28:69-76.